medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Number 3

<< Back Next >>

Ann Hepatol 2013; 12 (3)

Impact of MELD score implementation on liver allocation: experience at a Brazilian center

da Silva MAG, de Medeiros FJA, Marroni C, Zanotelli ML, Cantisani G, de Mello BAB

Language: English
References: 35
Page: 440-447
PDF size: 112.89 Kb.


ABSTRACT

Introduction. Model for end-stage liver disease (MELD) is an accurate predictor of mortality in patients with cirrhosis, and has been used on liver allocation in Brazil since 2006. However, its impact on organ allocation, waiting list and post-transplant mortality is still poorly characterized. This study aimed to assess the impact of implementation of the MELD system on liver allocation and mortality after liver transplantation (LT) in Southern Brazil. Material and methods. Adult patients with chronic liver disease on the waiting list for primary deceased-donor LT were divided into two cohorts (pre- and post-MELD implementation) according to the date of waiting list placement. Disease severity, as assessed by MELD score at placement, was similar in both cohorts. Patients were followed for at least 18 months to assess the outcomes of interest (death/LT). Results. Higher MELD scores correlated with waiting list mortality, which increased 20% with each additional point (HR 1.2; 95%CI 1.14-2.26; p ‹ 0.001). Waiting list mortality was 30.9% before and 21.7% after MELD implementation (nonsignificant). Transplant rate increased after MELD implementation (52 vs. 40%, p = 0.002). After excluding patients with hepatocellular carcinoma, mean MELD scores at LT were significantly higher in the MELD era (p ‹ 0.01). There was no significant correlation between MELD scores at LT and post-LT survival. During 18-month follow-up, post-LT mortality rate was 25.4% before and 20% after MELD implementation (nonsignificant). Conclusion. MELD implementation was associated with a reduction in waiting list mortality. Although sicker patients received LT in the MELD era, post-transplant survival was similar in both periods.


REFERENCES

  1. Brasil, Ministério da Saúde. In. Portaria no 1.160 de 29 de maio de 2006. Secretaria de Assistência à Saúde, 2006.

  2. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.

  3. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.

  4. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7-15.

  5. Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl 2007; 13: 1564-9.

  6. Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg 2007; 142: 1079-85.

  7. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, Wiesner RH. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004; 4: 819-25.

  8. Ravaioli M, Grazi GL, Ballardini G, Cavrini G, Ercolani G, Cescon M, Zanello M, et al. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant 2006; 6: 1572-7.

  9. Yoo HY, Thuluvath PJ. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int 2005; 25: 536-41.

  10. Freitas AC, Itikawa WM, Kurogi AS, Stadnik LG, Parolin MB, Coelho JC. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil. Arq Gastroenterol 2010; 47: 233-7.

  11. Monteiro F, Coria SA, Boni R, Pereira LA. Model for endstage liver disease: impact of the new deceased donor liver allocation policy in Sao Paulo, Brazil. Transplant Proc 2009; 41: 226-8.

  12. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3: 628-37.

  13. United Network for Organ Sharing, 20 abr. 2011. National Data Website. Available at: URL http://www.unos.org/ donation/index.php?topic=organ_allocation [Access: April 20].

  14. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.

  15. Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, et al. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci 2006; 51: 1070-8.

  16. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the prevs. post-MELD eras. Aliment Pharmacol Ther 2005; 21: 169-77.

  17. Wiesner RH. Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl 2005; 11: 261-3.

  18. Cholongitas E, Marelli L, Kerry A, Goodier DW, Nair D, Thomas M, Patch D, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores— a systematic bias. Am J Transplant 2007; 7: 685-92.

  19. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle- Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300: 2371-8.

  20. Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54: 462-70.

  21. Benckert C, Quante M, Thelen A, Bartels M, Laudi S, Berg T, Kaisers U, et al. Impact of the MELD allocation after its implementation in liver transplantation. Scand J Gastroenterol 2011; 46: 941-8.

  22. Brown RS Jr., Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, Lobritto S, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8: 278-84.

  23. Ferraz-Neto BH. MELD score, step forward to justice of liver graft allocation in Brazil. Arq Gastroenterol 2007; 44: 187-8.

  24. Gish RG. Do we need to MEND the MELD? Liver Transpl 2007; 13: 486-7.

  25. Teixeira AC, Souza FF, Mota G de A, Martinelli A de L, Sankarankutty AK, Silva O de C. Liver transplantation: expectation with MELD score for liver allocation in Brazil. Acta Cir Bras 2006; 21(Suppl. 1): 12-4.

  26. Davis CL. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006; 12: 707-9.

  27. Brandao A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G. MELD and other predictors of survival after liver transplantation. Clin Transplant 2009; 23: 220-7.

  28. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, Fasola CG, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003; 3: 626-30.

  29. Kim W, Wiesner R, Kamath P, Malinchoc M, Kremers WK, Rosen CB, Dickson ER, et al. Prediction of liver transplant outcome using the MELD scale. Am J Transplant 2001; 1(Suppl. 1): 284.

  30. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117-23.

  31. Gleisner AL, Munoz A, Brandao A, Marroni C, Zanotelli ML, Cantisani GG, Moreira LB, et al. Survival benefit of liver transplantation and the effect of underlying liver disease. Surgery 2010; 147: 392-404.

  32. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-13.

  33. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: Strengths and weaknesses. J Hepatol 2011; 54: 1297-306.

  34. Freeman RB. A decade of model for end-stage liver disease: lessons learned and need for re-evaluation of allocations policies. Curr Opin Organ Transplant 2012; 17: 211-5.

  35. Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Sex-based disparities in liver transplant rates in the United States. Am J Transplant 2011; 11: 1435-43.




2020     |     www.medigraphic.com